WHO ICTRP trial
Prevention of Stroke in Survivors of Brain Bleeding with Atrial Fibrillation
EUCTR2018-002176-41-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2018-002176-41-ES |
|---|---|
| Public title | Prevention of Stroke in Survivors of Brain Bleeding with Atrial Fibrillation |
| Scientific title | PREvention of STroke in Intracerebral haemorrhaGE survivors with Atrial Fibrillation (PRESTIGE-AF) - PRESTIGE-AF |
| Primary sponsor | Imperial College of Science, Technology and Medicine |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Spain;Germany |
| Conditions | Ischaemic stroke prevention in patients with atrial fibrillation and previous intracerebral haemorrhage;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] |
| Interventions | Trade Name: Eliquis Product Name: Eliquis Pharmaceutical Form: Film-coated tablet INN or Proposed INN: APIXABAN Other descriptive name: Apixaban Concentration unit: mg milligram(s) Concentration type: range Concentration number: 2.5-5.0… |
| Registration date | Dec 4, 2019 |
| Target size | 654 |
| Secondary IDs | 17HH4268;2018-002176-41-DE |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: